INTERNATIONAL PATENT: SHENZHEN HAOSHI BIOTECHNOLOGY CO., LTD, 深圳豪石生物科技有限公司 FILES APPLICATION FOR "USE OF GPRC5D SINGLE-DOMAIN ANTIBODY AND HUMANIZED ANTIBODY THEREOF IN CONSTRUCTION OF CAR-T CELL"
GENEVA, May 18 -- SHENZHEN HAOSHI BIOTECHNOLOGY CO., LTD (Building 2 Floor 7, Innovation Wisdomport, No.155 Hongtian Road, Xinqiao Street, Bao'an DistrictShenzhen, Guangdong 518104), 深圳豪石生物科技有限公司 (中国广东省深圳市宝安区新桥街道黄埔社区洪田路155号创新智慧港2栋7层) filed a patent application (PCT/CN2025/132816) for "USE OF GPRC5D SINGLE-DOMAIN ANTIBODY AND HUMANIZED ANTIBODY THEREOF IN CONSTRUCTION OF CAR-T CELL" on Nov 05, 2025. With publication no. WO/2026/098523, the details relat...
Click here to read full article from source
इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया
हमे संपर्क करें.